Two Sigma Advisers’s Cabaletta Bio CABA Stock Holding History
Bought
Maintained
Sold
Other funds holding CABA
BCLSI
CAM
VCM
Two Sigma Advisers's CABA Position: Q1 2026 in Review
Two Sigma Advisers sold out of Cabaletta Bio (CABA) in Q1 2026, closing a stake of 737,900 shares — an estimated $1.62M sold.
Two Sigma Advisers first reported a position in CABA in Q2 2020 and held it in 17 quarters. The position peaked at $1.89M in Q4 2024. 108 funds tracked by Wall St. Rank hold CABA as of Q1 2026.
- Two Sigma Advisers reported no remaining Cabaletta Bio position as of Q1 2026 after selling out during the quarter.
- Two Sigma Advisers sold 737,900 Cabaletta Bio shares in Q1 2026, an estimated $1.62M.
- Two Sigma Advisers first reported a position in Cabaletta Bio in Q2 2020 and held it in 17 quarters.
- Two Sigma Advisers's Cabaletta Bio position peaked at $1.89M in Q4 2024.
- 108 funds tracked by Wall St. Rank held Cabaletta Bio as of Q1 2026.
Based on Two Sigma Advisers's 13F filing for Q1 2026.